BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 2966205)

  • 21. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
    Ng YC; Schifferli JA; Walport MJ
    Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse monoclonal antibodies to the human C3b receptor.
    Cook J; Fischer E; Boucheix C; Mirsrahi M; Jouvin MH; Weiss L; Jack RM; Kazatchkine MD
    Mol Immunol; 1985 May; 22(5):531-9. PubMed ID: 3160931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of human T lymphocytes that express the C3b receptor.
    Wilson JG; Tedder TF; Fearon DT
    J Immunol; 1983 Aug; 131(2):684-9. PubMed ID: 6223090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ligand-loaded but not free complement receptors for C3b/C4b and C3d co-cap with cross-linked B cell surface IgM and IgD.
    Tsokos GC; Thyphronitis G; Jack RM; Finkelman FD
    J Immunol; 1988 Aug; 141(4):1261-6. PubMed ID: 2969399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PMA induces the ligand-independent internalization of CR1 on human neutrophils.
    Changelian PS; Jack RM; Collins LA; Fearon DT
    J Immunol; 1985 Mar; 134(3):1851-8. PubMed ID: 3155775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential interaction of the C3b/C4b receptor and MHC class I with the cytoskeleton of human neutrophils.
    Jack RM; Ezzell RM; Hartwig J; Fearon DT
    J Immunol; 1986 Dec; 137(12):3996-4003. PubMed ID: 2946771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils.
    O'Shea JJ; Brown EJ; Seligmann BE; Metcalf JA; Frank MM; Gallin JI
    J Immunol; 1985 Apr; 134(4):2580-7. PubMed ID: 3156186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
    Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A
    J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface markers of complement receptor lymphocytes.
    Ross GD; Winchester RJ; Rabellino EM; Hoffman T
    J Clin Invest; 1978 Nov; 62(5):1086-92. PubMed ID: 711854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
    Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
    Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional properties of membrane-associated complement receptor CR1.
    Iida K; Nussenzweig V
    J Immunol; 1983 Apr; 130(4):1876-80. PubMed ID: 6220069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors.
    Baiu DC; Prechl J; Tchorbanov A; Molina HD; Erdei A; Sulica A; Capel PJ; Hazenbos WL
    J Immunol; 1999 Mar; 162(6):3125-30. PubMed ID: 10092761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct evidence for the clustered nature of complement receptors type 1 on the erythrocyte membrane.
    Paccaud JP; Carpentier JL; Schifferli JA
    J Immunol; 1988 Dec; 141(11):3889-94. PubMed ID: 2972779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of neutrophil expression of C3b receptors (CR1) by soluble monomeric human C3b.
    Porteu F; Mir A; Halbwachs-Mecarelli L
    Eur J Immunol; 1987 May; 17(5):629-35. PubMed ID: 2953614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective complement receptors (CR1 and CR3) on erythrocytes and leukocytes of factor I (C3b-inactivator) deficient patients.
    Porteu F; Fischer A; Descamps-Latscha B; Halbwachs-Mecarelli L
    Clin Exp Immunol; 1986 Nov; 66(2):463-71. PubMed ID: 2949901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of immunological memory and T-independent humoral responses by monoclonal antibodies specific for murine complement receptors.
    Wiersma EJ; Kinoshita T; Heyman B
    Eur J Immunol; 1991 Oct; 21(10):2501-6. PubMed ID: 1717285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ligand specificities of mouse complement receptor types 1 (CR1) and 2 (CR2) purified from spleen cells.
    Pramoonjago P; Takeda J; Kim YU; Inoue K; Kinoshita T
    Int Immunol; 1993 Apr; 5(4):337-43. PubMed ID: 7684250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phagocytosis by human monocyte-derived macrophages. Independent function of receptors for C3b (CR1) and iC3b (CR3).
    Newman SL; Devery-Pocius JE; Ross GD; Henson PM
    Complement; 1984; 1(4):213-27. PubMed ID: 6242391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of rat complement receptors and regulatory proteins. CR2 and Crry are conserved, and the C3b receptor of neutrophils and platelets is distinct from CR1.
    Quigg RJ; Holers VM
    J Immunol; 1995 Aug; 155(3):1481-8. PubMed ID: 7636211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.